RNA, 7SL, cytoplasmic 217, pseudogene (RN7SL217P)

RN7SL217P is a pseudogene derived from the sequence of 7SL RNA, a non-coding RNA that is a critical structural component of the signal recognition particle (SRP) involved in cotranslational targeting of secretory proteins to the endoplasmic reticulum[1][6][7]. However, as a pseudogene, RN7SL217P is a non-functional genomic sequence that resembles the functional 7SL RNA gene but does not produce a functional RNA product. Hundreds of such 7SL RNA-derived pseudogenes have been identified throughout the human genome, generally as inactive, truncated copies, and are not implicated in protein function, disease, or as drug targets[7]. While the parental 7SL RNA and components of the SRP complex have clear cellular roles[3][6], there is no evidence that RN7SL217P has any biological function or relevance in disease, therapy, or as a biomarker[1][7]. Key context: - Pseudogenes are typically defined as molecular fossils—genomic sequences similar to known genes but rendered nonfunctional by mutations[4][7]. - In rare cases, some pseudogenes may acquire regulatory roles (e.g., as miRNA decoys), but there are no reports linking RN7SL217P to such functions[4]. - The parent 7SL RNA, when functional, is a core part of the SRP complex that mediates protein targeting to the endoplasmic reticulum during synthesis[3][6]. Bottom line: RN7SL217P is not a therapeutic target but a non-functional pseudogene related to 7SL RNA, with no known biological relevance or clinical application[1][7].

Other names

RN7SL217P